Anti-thrombotic medication significantly reduces risk of death for heart attack patients

standard approaches to antithrombotic therapy in patients with STEMI in preventing death or reinfarction (additional heart attack) at 30 days. These outcomes were also assessed at 9 days and at study end (minimum of 3 and maximum of 6 months). The study included 12,092 patients with STEMI from 447 hospitals in 41 countries who were randomized to receive fondaparinux 2.5 mg once daily for up to 8 days or usual care (placebo in those in whom UFH is not indicated or UFH for up to 48 hours followed by placebo for up to 8 days in patients with STEMI).

The researchers found that death or reinfarction at 30 days was significantly reduced from 11.2 percent of 6,056 patients in the control group to 9.7 percent of 6,036 patients in the fondaparinux group, a risk reduction of 14 percent. These benefits were observed at 9 days (8.9 percent) placebo vs. (7.4 percent) fondaparinux, a 17 percent risk reduction; and at study end (14.8 percent) placebo vs. (13.4 percent) fondaparinux, a 12 percent reduction. Risk of death was significantly reduced throughout the study. However, there was no benefit in those undergoing primary PCI. There was a tendency to fewer severe bleeding events in the fondaparinux group.

"In summary, fondaparinux reduces mortality and reinfarction early, and this benefit persists long term," the authors write. " results from OASIS-6 confirm the value and safety of fondaparinux as a simple and widely applicable antithrombotic therapy in a broad group of patients with acute coronary syndrome."


Contact: Veronica McGuire
JAMA and Archives Journals

Page: 1 2

Related medicine news :

1. Adding medication improves recovery for elderly with depression, says Pitt School of Medicine study
2. Heart failure medication does not improve survival, compared to more widely used medication
3. Commonly used pain medications do not prevent Alzheimers disease
4. Standard long-acting insulin as good as newer medications
5. MS patients not receiving medications to slow disease progression, research shows
6. Study sheds light on medication treatment options for bipolar disorder
7. Landmark schizophrenia treatment study reveals that medication alone is not always effective
8. Cost control measures limit patient and physician choice in psychotropic medications
9. Residents in disaster areas face medication adherence dilemmas
10. Improved adherence to certain medications associated with longer survival following heart attack
11. Many children discontinuing use of ADHD medication

Post Your Comments:

(Date:7/7/2020)... PORTLAND, Ore. (PRWEB) , ... July 07, 2020 ... ... and a unique one or two head design to efficiently sanitize large surfaces ... https://www.germ-fogger.mx , is now available to support sales in that region. , In ...
(Date:7/4/2020)... ... ... Houston Life coach, Rashad Garrett, has thrown a lifeline to those struggling with ... app, Faith Of A Mustard Seed (FOAMS). , The global pandemic has caused a ... a Federal Agency emergency helpline dedicated to helping people in emotional distress registered more ...
(Date:7/2/2020)... ... July 02, 2020 , ... Temprian, a spinoff from Northwestern ... Its lead indication is vitiligo. Vitiligo patients develop progressive depigmentation of the skin. ... vitiligo is equally prevalent in all ethnic groups, it is most visible and ...
(Date:7/2/2020)... ... July 02, 2020 , ... Columbia Southern University ... the Year Award to Eric Simmons of Temecula, California. , CSU’s occupational ... who holds a master’s degree in occupational safety and health from the university, ...
(Date:7/2/2020)... ... 2020 , ... The Coronavirus (COVID-19) pandemic resulted in the ... with the American Dental Association and Centers for Disease Control and Prevention, Governor ... to safety concerns, the announcement sparked hesitancy among some hygienists, who protested their ...
Breaking Medicine News(10 mins):
(Date:7/1/2020)... YORK (PRWEB) , ... July 01, 2020 , ... Dexur’s ... that University Hospitals Ahuja Medical Center , Southwest General Health Center , ... 90 day episode for Hip & Knee replacement. Dexur’s value analysis tracks a patient’s ...
(Date:7/1/2020)... SAN FRANCISCO (PRWEB) , ... July 01, 2020 ... ... for the first time ever, Stratodesk NoTouch OS is available on NComputing devices. ... NComputing device, both NComputing and Stratodesk have formed a new partnership that will ...
(Date:6/28/2020)... ... June 27, 2020 , ... CPAP Store USA, known for its one of ... devices, is growing and expanding at a rapid rate. Today, CPAP store USA is ... CPAP Store Dallas, located at 3920 Rosemeade Parkway, Suite 150, Dallas, Texas 75287. , ...
Breaking Medicine Technology:
Cached News: